| 1 |
matrix metalloproteinase
(12329 times)
|
Neoplasms
(1672 times)
|
TIMP (1158 times)
IL (936 times)
ECM (682 times)
|
1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
|
| 2 |
mitochondrial membrane potential
(3788 times)
|
Pharmacology
(455 times)
|
ROS (1872 times)
MDA (222 times)
SOD (209 times)
|
1992 Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes.
|
| 3 |
mucous membrane pemphigoid
(260 times)
|
Dermatology
(91 times)
|
BP (31 times)
BMZ (23 times)
PV (23 times)
|
1985 Localization of basement membrane components in mucous membrane pemphigoid.
|
| 4 |
monomethyl phthalate
(110 times)
|
Environmental Health
(79 times)
|
MEHP (57 times)
MEP (53 times)
MBP (43 times)
|
1991 Mutagenicity and metabolism of dimethyl phthalate and its binding to epidermal and hepatic macromolecules.
|
| 5 |
Medical Monitoring Project
(56 times)
|
Acquired Immunodeficiency Syndrome
(23 times)
|
ART (15 times)
HIV (15 times)
CI (7 times)
|
2007 Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.
|
| 6 |
matched molecular pair
(32 times)
|
Chemistry
(14 times)
|
SAR (7 times)
MMPA (3 times)
QSAR (3 times)
|
2010 Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
|
| 7 |
membrane potential
(21 times)
|
Neurology
(4 times)
|
ROS (7 times)
ER (3 times)
mPTP (2 times)
|
1996 Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level.
|
| 8 |
methadone maintenance program
(21 times)
|
Medicine
(6 times)
|
AMP (2 times)
DFP (2 times)
HIV (2 times)
|
1989 [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
|
| 9 |
microsatellite mutator phenotype
(18 times)
|
Neoplasms
(8 times)
|
MMR (3 times)
AP-PCR (2 times)
MSI (2 times)
|
1995 The microsatellite mutator phenotype of colon cancer cells is often recessive.
|
| 10 |
magnetic microparticle
(14 times)
|
Biotechnology
(3 times)
|
BCA (5 times)
BTV (2 times)
GNP (2 times)
|
2006 Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles.
|
| 11 |
major membrane protein
(14 times)
|
Allergy and Immunology
(5 times)
|
BCG (5 times)
DC (4 times)
HSP (4 times)
|
1990 The major native proteins of the leprosy bacillus.
|
| 12 |
masticatory myofascial pain
(13 times)
|
Dentistry
(6 times)
|
VAS (5 times)
PPT (4 times)
CV-angle (2 times)
|
2002 Masticatory myofascial pain: an explanatory model integrating clinical, epidemiological and basic science research.
|
| 13 |
matrix-degrading metalloproteinase
(13 times)
|
Vascular Diseases
(4 times)
|
TIMP (2 times)
UVB (2 times)
VSMC (2 times)
|
1997 Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines.
|
| 14 |
masticatory muscle pain
(12 times)
|
Dentistry
(10 times)
|
MPI (2 times)
TMD (2 times)
EMG (1 time)
|
1998 Psychological and physiological parameters of masticatory muscle pain.
|
| 15 |
methadone maintenance patients
(11 times)
|
Substance-Related Disorders
(8 times)
|
BMP (2 times)
WCST (2 times)
ADHD (1 time)
|
1995 Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
|
| 16 |
Mini-Mental Parkinson
(11 times)
|
Neurology
(4 times)
|
MMSE (7 times)
PD (4 times)
ACE-R (2 times)
|
2010 Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
|
| 17 |
2-methoxy-4-methylphenol
(8 times)
|
Neoplasms
(3 times)
|
HDO (3 times)
BPO (2 times)
HSG (2 times)
|
2004 Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.
|
| 18 |
mean melting point
(8 times)
|
Endocrinology
(3 times)
|
FA (3 times)
PL (3 times)
DBI (2 times)
|
1991 Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.
|
| 19 |
minimum miscibility pressure
(8 times)
|
Chemistry Techniques, Analytical
(2 times)
|
CO2-EOR (1 time)
FCM (1 time)
HPHT (1 time)
|
2005 Determination of gas-oil miscibility conditions by interfacial tension measurements.
|
| 20 |
mitochondrial myopathy
(8 times)
|
Cardiology
(4 times)
|
BMD (4 times)
CI (3 times)
MD (3 times)
|
1996 [Heart muscle involvement in myopathies].
|
| 21 |
maximal mean power
(7 times)
|
Sports Medicine
(5 times)
|
AT (1 time)
BCM (1 time)
CP (1 time)
|
2005 Power output during women's World Cup road cycle racing.
|
| 22 |
maximal mean power output
(7 times)
|
Sports Medicine
(5 times)
|
CP (2 times)
MT (1 time)
PCSpoints (1 time)
|
2015 Impact of Altitude on Power Output during Cycling Stage Racing.
|
| 23 |
mean maximal power
(7 times)
|
Sports Medicine
(7 times)
|
CP (2 times)
PT (2 times)
WT (2 times)
|
2020 Training Characteristics and Power Profile of Professional U23 Cyclists throughout a Competitive Season.
|
| 24 |
medication management program
(7 times)
|
Health Services Research
(2 times)
|
ARMIN (1 time)
CI (1 time)
CPs (1 time)
|
2015 Pharmacist-led medication management program within a patient-centered medical home.
|
| 25 |
membrane mitochondrial potential
(7 times)
|
Pediatrics
(1 time)
|
ROS (3 times)
LDHA (2 times)
A. muricata (1 time)
|
2009 Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis.
|
| 26 |
modified Mallampati grade
(7 times)
|
Otolaryngology
(7 times)
|
BMI (6 times)
AHI (5 times)
OSA (3 times)
|
1999 Clinical predictors of obstructive sleep apnea.
|
| 27 |
multichannel matching pursuit
(7 times)
|
Neurology
(4 times)
|
EEG (2 times)
ICA (2 times)
SVM (2 times)
|
2009 Inverse modeling on decomposed electroencephalographic data: a way forward?
|
| 28 |
Marine Mammal Program
(6 times)
|
Veterinary Medicine
(4 times)
|
EBC (1 time)
GGT (1 time)
|
2008 Trace and non-trace elements in blood cells of bottlenose dolphins (Tursiops truncatus): variations with values from liver function indicators.
|
| 29 |
medium molecular peptides
(6 times)
|
Urology
(2 times)
|
EI (2 times)
AOMP (1 time)
ATFE (1 time)
|
1991 [Blood levels of medium molecular weight peptides and lipid peroxidation activity in the differential diagnosis of diffuse toxic goiter].
|
| 30 |
metabolites, monomethyl phthalate
(6 times)
|
Environmental Health
(3 times)
|
MEP (5 times)
MEHP (4 times)
mBP (3 times)
|
2003 Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
|
| 31 |
modified Mallampati
(6 times)
|
Anesthesiology
(4 times)
|
BMI (2 times)
AASI (1 time)
CL (1 time)
|
2006 Craniocervical extension improves the specificity and predictive value of the Mallampati airway evaluation.
|
| 32 |
modulate metalloproteinase
(6 times)
|
Physiology
(2 times)
|
AD (1 time)
Ang (1 time)
Ang II (1 time)
|
2003 Regulation of trophoblastic gelatinases by proto-oncogenes.
|
| 33 |
Multiple Multipole Program
(6 times)
|
Biophysics
(3 times)
|
LSPR (2 times)
AFM (1 time)
FEM (1 time)
|
2005 Induced current density in the foetus of pregnant workers in high magnetic field environments.
|
| 34 |
methylmannose polysaccharide
(5 times)
|
Biochemistry
(3 times)
|
AMMP (1 time)
Ea (1 time)
FAs (1 time)
|
1977 Acetylated methylmannose polysaccharide of Streptomyces.
|
| 35 |
Mexican Migration Project
(5 times)
|
Social Medicine
(1 time)
|
MAFE (1 time)
MEPS (1 time)
PPACA (1 time)
|
2015 Mexican Immigrant Health: Health Insurance Coverage Implications.
|
| 36 |
middle mass peptides
(5 times)
|
Pharmacology
(2 times)
|
---
|
1986 [Role of middle-molecule blood peptides in the development of cardiac depression in thermal burns].
|
| 37 |
minimum morbidity percentile
(5 times)
|
Environmental Health
(3 times)
|
OHCA (4 times)
DLNM (1 time)
MMT (1 time)
|
2016 Extreme temperature and out-of-hospital cardiac arrest in Japan: A nationwide, retrospective, observational study.
|
| 38 |
Mueller matrix polarimetry
(5 times)
|
Ophthalmology
(3 times)
|
CP (1 time)
LP (1 time)
MM (1 time)
|
2017 Use of Mueller matrix polarimetry and optical coherence tomography in the characterization of cervical collagen anisotropy.
|
| 39 |
multidimensional multiscale parser
(5 times)
|
Medical Informatics
(3 times)
|
HEVC (1 time)
PDS (1 time)
SbS (1 time)
|
2008 Universal image compression using multiscale recurrent patterns with adaptive probability model.
|
| 40 |
maximum mean pressure
(4 times)
|
Orthopedics
(3 times)
|
PP (3 times)
FTI (2 times)
BSI (1 time)
|
2005 The effect of terrain on foot pressures during walking.
|
| 41 |
metal matrix proteinase
(4 times)
|
Neoplasms
(2 times)
|
AQP3 (1 time)
ECM (1 time)
GMFB (1 time)
|
2013 Effect of Chinese herbs on immunoglobulin A nephropathy: a randomized controlled trial.
|
| 42 |
Microminipig
(4 times)
|
Pharmacology
(2 times)
|
CE (2 times)
HDL-C (2 times)
HFCD/SC (2 times)
|
2011 Microminipig, a non-rodent experimental animal optimized for life science research:novel atherosclerosis model induced by high fat and cholesterol diet.
|
| 43 |
mindfulness meditation practice
(4 times)
|
Psychophysiology
(1 time)
|
ANS (1 time)
MBCT (1 time)
MMD (1 time)
|
2014 Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
|
| 44 |
modified multiple platform
(4 times)
|
Brain
(2 times)
|
PSD (2 times)
CPSD (1 time)
DA (1 time)
|
2004 Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery.
|
| 45 |
movement-monitoring potentials
(4 times)
|
Brain
(2 times)
|
MP (2 times)
MRCP (2 times)
MRPs (2 times)
|
2004 Relationship between plantar-flexor torque generation and the magnitude of the movement-related potentials.
|
| 46 |
malignant mesothelioma of the pleura
(3 times)
|
Medicine
(1 time)
|
Can-Qc (1 time)
|
1985 Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia.
|
| 47 |
matrix metalloproteinase-tissue inhibitor of metalloproteinase
(3 times)
|
Respiratory Tract Diseases
(1 time)
|
AIA (1 time)
COP (1 time)
OP (1 time)
|
1998 Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
|
| 48 |
medial midpatellar
(3 times)
|
Drug Delivery Systems
(1 time)
|
AM (2 times)
AL (1 time)
ALJL (1 time)
|
2006 Comparison of four different intra-articular injection sites in the knee: a cadaver study.
|
| 49 |
medical marijuana patients
(3 times)
|
Substance-Related Disorders
(3 times)
|
MM (2 times)
NPU (2 times)
|
2016 Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users.
|
| 50 |
medicine management plan
(3 times)
|
Geriatrics
(1 time)
|
DMS (1 time)
MRH (1 time)
RPT (1 time)
|
2022 Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trial.
|
| 51 |
methylmercaptopurine
(3 times)
|
Pharmacology
(2 times)
|
6-MP (1 time)
AZA (1 time)
MP (1 time)
|
2002 Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.
|
| 52 |
micro manipulating probe
(3 times)
|
Diagnostic Imaging
(2 times)
|
FEM (1 time)
|
2017 Controlled removal of micro/nanoscale particles in submillimeter-diameter area on a substrate.
|
| 53 |
micro-magnetic particle
(3 times)
|
Chemistry Techniques, Analytical
(2 times)
|
ABC (3 times)
BBC (2 times)
cyto c (2 times)
|
2013 An aptamer-based bio-barcode assay with isothermal recombinase polymerase amplification for cytochrome-c detection and anti-cancer drug screening.
|
| 54 |
modified Maquet procedure
(3 times)
|
Veterinary Medicine
(3 times)
|
CCLR (1 time)
PVF (1 time)
TPLO (1 time)
|
2016 The Modified Maquet Procedure (MMP) in Dogs: Technical Development and Initial Clinical Experience.
|
| 55 |
Montana Meth Project
(3 times)
|
Health Services
(2 times)
|
METH (1 time)
TEDS (1 time)
YRBS (1 time)
|
2008 Drugs, money, and graphic ads: a critical review of the Montana Meth Project.
|
| 56 |
Mucous membrane plasmacytosis
(3 times)
|
Otolaryngology
(2 times)
|
B-CLL (1 time)
|
2008 Mucous membrane plasmacytosis of the nose in a patient affected by B-cell chronic lymphocytic leukemia.
|
| 57 |
Multi-Muscle Pattern
(3 times)
|
Physiology
(3 times)
|
AFL (1 time)
BMI (1 time)
EMGs (1 time)
|
2008 Spherical classification of wavelet transformed EMG intensity patterns.
|
| 58 |
multicellular magnetotactic prokaryote
(3 times)
|
Microbiology
(2 times)
|
DMO (1 time)
|
2006 Magnetic optimization in a multicellular magnetotactic organism.
|
| 59 |
multiple multipole
(3 times)
|
Biomedical Engineering
(1 time)
|
AFM (1 time)
AMS (1 time)
FD (1 time)
|
1993 Multiple multipole method for simulating EM problems involving biological bodies.
|
| 60 |
myristoylated membrane protein
(3 times)
|
Allergy and Immunology
(1 time)
|
LCDV (2 times)
LCDV-PF (2 times)
MCP (2 times)
|
2014 Identification of lymphocystis disease virus from paradise fish Macropodus opercularis (LCDV-PF).
|
| 61 |
1-methoxy-5-methylphenazinium
(2 times)
|
Chemistry Techniques, Analytical
(2 times)
|
MP (1 time)
PCOP (1 time)
|
1999 Uricase-catalyzed oxidation of uric acid using an artificial electron acceptor and fabrication of amperometric uric acid sensors with use of a redox ladder polymer.
|
| 62 |
macrophage metalloprotease
(2 times)
|
Pulmonary Medicine
(1 time)
|
AAD (1 time)
BAL (1 time)
CAS (1 time)
|
2006 Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice.
|
| 63 |
magnetotactic multicellular prokaryote
(2 times)
|
Biophysics
(1 time)
|
---
|
2004 Observation of magnetoreceptive behavior in a multicellular magnetotactic prokaryote in higher than geomagnetic fields.
|
| 64 |
MammaPrint
(2 times)
|
Neoplasms
(1 time)
|
BCI (1 time)
CI (1 time)
EBC (1 time)
|
2019 Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score (RS) assay and other genomic assays for early breast cancer.
|
| 65 |
many-celled magnetotactic prokaryotes
(2 times)
|
Diagnostic Imaging
(1 time)
|
---
|
2006 Flagellar apparatus of south-seeking many-celled magnetotactic prokaryotes.
|
| 66 |
maximum mean power
(2 times)
|
Sports Medicine
(2 times)
|
PP (1 time)
|
2010 The power profile predicts road cycling MMP.
|
| 67 |
mean maximal power output
(2 times)
|
Physiology
(2 times)
|
---
|
2018 Sprinting for the Win: Distribution of Power Output in Women's Professional Cycling.
|
| 68 |
medication management pathway
(2 times)
|
Drug-Related Side Effects and Adverse Reactions
(1 time)
|
AF (1 time)
MEs (1 time)
|
2011 A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.
|
| 69 |
Medium-weight molecular peptide
(2 times)
|
Therapeutics
(2 times)
|
DTG (1 time)
LPO (1 time)
|
1991 [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
|
| 70 |
membrane peptide
(2 times)
|
Allergy and Immunology
(1 time)
|
MAP (2 times)
APC (1 time)
CTL (1 time)
|
2019 A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
|
| 71 |
mesenteric malperfusion
(2 times)
|
Vascular Diseases
(2 times)
|
ABAD (1 time)
FL (1 time)
SMA (1 time)
|
2019 Mesenteric Malperfusion in Acute Aortic Dissection: Challenges and Frontiers.
|
| 72 |
metalloproteinase matrix
(2 times)
|
Jurisprudence
(1 time)
|
---
|
2003 [Immunohistochemical findings in prolonged cerebral hypoxia].
|
| 73 |
metalloproteinases of matrix
(2 times)
|
Pulmonary Medicine
(1 time)
|
Lm (2 times)
MAC (2 times)
BMDM (1 time)
|
2017 A murine model of elastase- and cigarette smoke-induced emphysema.
|
| 74 |
metastatic melanoma patients
(2 times)
|
Neoplasms
(1 time)
|
BRAFi (1 time)
CI (1 time)
HR (1 time)
|
2015 The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.
|
| 75 |
metastatic proteins metalloproteinase
(2 times)
|
Biochemistry
(1 time)
|
AGS (1 time)
AST (1 time)
ROS (1 time)
|
2009 Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk.
|
| 76 |
Million Mutation Project
(2 times)
|
Genetics
(2 times)
|
PhenoMIP (1 time)
WGS (1 time)
|
2016 Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies.
|
| 77 |
mitochondrial membrane-phospholipid
(2 times)
|
Digestive System Surgical Procedures
(1 time)
|
CoQ10 (1 time)
DCM (1 time)
omega-3 PUFAs (1 time)
|
1996 Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy.
|
| 78 |
Mixed methods psychometrics
(2 times)
|
Medicine
(1 time)
|
PRO (2 times)
CTT (1 time)
MG (1 time)
|
2021 Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
|
| 79 |
mixed muscle protein
(2 times)
|
Endocrinology
(1 time)
|
MHC (2 times)
GC-C-IRMS (1 time)
SDS-PAGE (1 time)
|
1997 Skeletal muscle myosin heavy chain synthesis in type 1 diabetes.
|
| 80 |
mizoribine 5'-monophosphate
(2 times)
|
Biochemistry
(2 times)
|
IMPDH (2 times)
TAD (1 time)
|
1995 Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
|
| 81 |
mobile measurement platform
(2 times)
|
Environmental Health
(2 times)
|
BC (1 time)
CO (1 time)
EMFAC (1 time)
|
2011 Emission factors for high-emitting vehicles based on on-road measurements of individual vehicle exhaust with a mobile measurement platform.
|
| 82 |
mono-methyl mono-phosphate ester
(2 times)
|
Chemistry
(2 times)
|
NBO (1 time)
NEDA (1 time)
QM/MM (1 time)
|
2007 Interactions between phosphate and water in solution: a natural bond orbital based analysis in a QM/MM framework.
|
| 83 |
mulberry marc purification
(2 times)
|
Nutritional Sciences
(1 time)
|
MJP (1 time)
|
2013 Antioxidant and anti-fatigue effects of anthocyanins of mulberry juice purification (MJP) and mulberry marc purification (MMP) from different varieties mulberry fruit in China.
|
| 84 |
Multifactor Measure of Performance
(2 times)
|
Cognitive Science
(1 time)
|
---
|
2022 The Bar-On Model and Multifactor Measure of Human Performance: Validation and Application.
|
| 85 |
Mycophenolate mophetil
(2 times)
|
Ophthalmology
(1 time)
|
HSA (1 time)
MPA (1 time)
|
2012 Mycophenolate mofetil use in the treatment of noninfectious uveitis.
|
| 86 |
myosin/moesin phosphatase
(2 times)
|
Cell Biology
(1 time)
|
Inh-2 (1 time)
PP1 (1 time)
|
2000 Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading.
|
| 87 |
peroxynitrite-matrix metalloproteinase
(2 times)
|
Cardiology
(1 time)
|
CAD (1 time)
iNOS (1 time)
LVEF (1 time)
|
2010 Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
|
| 88 |
2-methoxy-2-methyl propanal
(1 time)
|
Biology
(1 time)
|
MMP-acid (1 time)
MMP-OH (1 time)
MTBE (1 time)
|
2009 Advanced oxidation and reduction process chemistry of methyl tert-butyl ether (MTBE) reaction intermediates in aqueous solution: 2-methoxy-2-methyl-propanal, 2-methoxy-2-methyl-propanol, and 2-methoxy-2-methyl-propanoic acid.
|
| 89 |
2-methoxy-2-methyl propionaldehyde
(1 time)
|
Environmental Health
(1 time)
|
AC (1 time)
AOP (1 time)
FA (1 time)
|
2001 MTBE oxidation by conventional ozonation and the combination ozone/hydrogen peroxide: efficiency of the processes and bromate formation.
|
| 90 |
2-methoxy-6-methylpyridine
(1 time)
|
Medicine
(1 time)
|
MTBE (1 time)
|
2019 Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine.
|
| 91 |
3-mercaptomethylpropionate
(1 time)
|
Chemistry
(1 time)
|
MNIC (1 time)
|
2014 Transformation of a mononitrosyl iron complex to a [2Fe-2S] cluster by a cysteine analogue.
|
| 92 |
3-methyl-4-(methylthio)phenol
(1 time)
|
Environmental Health
(1 time)
|
hERalpha (1 time)
HPLC (1 time)
MMS (1 time)
|
2009 A novel estrogenic compound transformed from fenthion under UV-A irradiation.
|
| 93 |
3-O-methyl-D-mannose-containing polysaccharide
(1 time)
|
Biochemistry
(1 time)
|
SD-MMP (1 time)
|
1977 Heterogeneity and refined structtures of 3-O-methyl-D-mannose polysaccharides from Mycobacterium smegmatis.
|
| 94 |
70-Major Membrane Protein
(1 time)
|
Pulmonary Medicine
(1 time)
|
HSP (1 time)
Mtb (1 time)
|
2021 Production of antibiotic resistance gene-free urease-deficient recombinant BCG that secretes antigenic protein applicable for practical use in tuberculosis vaccination.
|
| 95 |
actin-collagen-matrix metalloproteinases
(1 time)
|
Medicine
(1 time)
|
NHP (1 time)
|
2011 Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.
|
| 96 |
c-Myc, p53, Bax, Bcl-2, metalloproteinase
(1 time)
|
Medicine
(1 time)
|
MDM2 (1 time)
VEGF (1 time)
|
2016 [Effect and Regulatory Mechanism of Clock Gene Per1 on Biological Behaviors of Human Oral Squamous Carcinoma Cell].
|
| 97 |
Epac1-to-matrix metalloprotease
(1 time)
|
Neurology
(1 time)
|
Epac1 (1 time)
|
2013 Role of HIF-1alpha-activated Epac1 on HSC-mediated neuroplasticity in stroke model.
|
| 98 |
ERalpha-CD147-matrix metalloproteinase
(1 time)
|
Biology
(1 time)
|
CAFs (1 time)
CM (1 time)
ERalpha (1 time)
|
2022 Estrogen-responsive cancer-associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production.
|
| 99 |
Fe3O4-magainins I nanocomposites
(1 time)
|
Chemistry
(1 time)
|
PIP (1 time)
|
2020 Sandwich immunoassay based on antimicrobial peptide-mediated nanocomposite pair for determination of Escherichia coli O157:H7 using personal glucose meter as readout.
|
| 100 |
lysoPC-mediated proliferation could occur by stimulating metalloproteinase
(1 time)
|
Pharmacology
(1 time)
|
lysoPC (1 time)
ox-LDL (1 time)
SMC (1 time)
|
2002 Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.
|
A Search Service for Abbreviation / Long Form